Fmoc-N-Methyl-L-Isoleucine

Product Overview

Fmoc-N-Methyl-L-Isoleucine represents a critical specialized building block in the realm of modern peptide chemistry and pharmaceutical development. As an N-methylated amino acid derivative protected by the Fluorenylmethyloxycarbonyl group, this compound plays a pivotal role in Solid Phase Peptide Synthesis (SPPS). The incorporation of N-methylated residues into peptide sequences is a strategic modification used to enhance metabolic stability, improve membrane permeability, and constrain conformational flexibility. These attributes are essential for developing next-generation peptide therapeutics that require improved bioavailability compared to their non-methylated counterparts.

Our manufacturing process ensures that each batch meets rigorous international standards for chemical purity and stereochemical integrity. The product is synthesized under controlled conditions to minimize racemization, ensuring that the (2S,3S) configuration is preserved throughout the production lifecycle. This level of precision is vital for researchers and pharmaceutical manufacturers who rely on consistent starting materials to produce reproducible results in drug discovery pipelines.

Technical Specifications

Quality control is paramount in the supply of fine chemical intermediates. We employ advanced analytical techniques including High-Performance Liquid Chromatography (HPLC) and Nuclear Magnetic Resonance (NMR) spectroscopy to verify the identity and purity of every lot. The physical properties listed below are typical values derived from our standard production runs. Customers receive a comprehensive Certificate of Analysis (COA) with every shipment to confirm compliance with specified parameters.

Industrial Applications

This protected amino acid is primarily utilized in the construction of complex peptide chains for medicinal chemistry applications. The N-methyl group introduces steric hindrance that can prevent enzymatic degradation by peptidases, thereby extending the half-life of the final peptide drug in biological systems. Common use cases include the synthesis of cyclic peptides, peptidomimetics, and active pharmaceutical ingredients (APIs) targeting various therapeutic areas such as oncology and metabolic disorders.

• Essential reagent for Solid Phase Peptide Synthesis (SPPS).
• Used to enhance metabolic stability in peptide drug candidates.
• Supports research into conformationally constrained bioactive molecules.
• Suitable for large-scale manufacturing of peptide intermediates.

Quality Assurance And Storage

To maintain the stability and efficacy of Fmoc-N-Methyl-L-Isoleucine, proper storage protocols must be followed. The compound should be kept in a cool, dry environment away from direct sunlight and moisture. We recommend storage temperatures between 2 to 8 degrees Celsius to prevent degradation of the Fmoc protecting group over extended periods. Packaging is designed to ensure integrity during transit, with options available for bulk industrial requirements including drums and customized containers.

As a global manufacturer, we are committed to providing reliable supply chains for the pharmaceutical and biotechnology sectors. Our facility adheres to strict safety and environmental guidelines, ensuring that all products are handled and shipped in full compliance with international regulations. For detailed technical support or custom synthesis requests, our team of experts is available to assist with your specific project requirements.